Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP
The first FDA-approved pacing lead specifically developed for LBBAP is now being implanted throughout the United States.
FDA approves smallest defibrillation lead of its kind for LBBA placement
The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.
Cardiology now has more than 200 FDA-cleared AI algorithms
Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3.
FDA shares details about reprocessed catheter recall
Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.
Boston Scientific’s Farapulse PFA system receives expanded approval
The technology first gained CE mark approval for the treatment of paroxysmal AFib in 2021, when PFA was still brand new. Now, thanks to positive results from the ADVANTAGE AF clinical trial, it is approved for persistent AFib as well.

FDA clears MRI-compatible EP mapping catheter

This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement.

Boston Scientific Farapoint pulsed field ablation (PFA) catheter

FDA approves Boston Scientific’s Farapoint PFA catheter

The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation.

AI healthcare doctor surgery procedure artificial intelligence

FDA clears next-generation platform for AI-enabled ECG evaluations

AccurECG 2.0 was designed to interpret a total of 13 different rhythm classifications, including atrial fibrillation, atrial flutter and ventricular tachycardia.

Magic Magnetic Interventional Ablation Catheter

Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter

This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.

Abbott PFA system gains FDA approval

The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.

heart data research doctor cardiologist AI

New PFA registry will use AI, EHR integration to gather real-world data

PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.

Success in treating congenital heart disease prompted need for new adult guidelines

The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.

Milestone Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for etripamil, a new nasal spray for adult patients with paroxysmal supraventricular tachycardia (PSVT).

FDA approves new nasal spray for patients with abnormal heart rhythms

Milestone Pharmaceuticals will be selling etripamil under the brand name Cardamyst. It is expected to hit the U.S. market in early 2026.

Electrophysiology

Cardiologist makes history with first commercial implant of new pacing lead for LBBAP

FDA approves smallest defibrillation lead of its kind for LBBA placement

Cardiology now has more than 200 FDA-cleared AI algorithms

FDA shares details about reprocessed catheter recall

Boston Scientific’s Farapulse PFA system receives expanded approval